Role of miR-16, 146a, 19b and 720 in Vitiligo
Author Information
Author(s): Olfat Shaker, Abd elrahim Talal A., Azzam Somia, El-Zook Mai Mohamed, Aboraia Nesreen M.
Primary Institution: Cairo University
Hypothesis
Can the expression levels of miR-16, 146a, 19b, and 720 be used as biomarkers for the early diagnosis of vitiligo?
Conclusion
The study found that miR-16, 146a, and 19b are overexpressed in vitiligo patients, while miR-720 is downregulated, suggesting their potential as early diagnostic biomarkers.
Supporting Evidence
- miR-16, 146a, and 19b were significantly overexpressed in vitiligo patients compared to healthy controls.
- miR-720 was significantly downregulated in vitiligo patients.
- Positive correlations were found between miR-16, 146a, and disease severity scores.
- ROC analysis indicated potential diagnostic accuracy for the biomarkers.
Takeaway
This study looked at certain tiny molecules in the blood that might help doctors find out if someone has vitiligo, a skin condition that causes white patches.
Methodology
The study involved analyzing serum and tissue levels of specific miRNAs in 20 vitiligo patients and 20 healthy controls using blood samples and skin biopsies.
Potential Biases
Potential selection bias due to the specific inclusion criteria for participants.
Limitations
The study had a small sample size and was limited to non-segmental vitiligo patients.
Participant Demographics
20 vitiligo patients (8 males, 12 females) and 20 healthy controls (7 males, 13 females), mean age approximately 36 years for both groups.
Statistical Information
P-Value
0.000
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website